RGRX / RegeneRx Biopharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

RegeneRx Biopharmaceuticals, Inc.
US ˙ OTCPK ˙ US75886X1081

Deler fremragende 1,508,591 shares
Insideraktier9.970.285 shares
Total Insiders22
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
8594 out of 10998

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
8878 out of 10864

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

RegeneRx Biopharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
S P A Aptafin - 1.500.000
Mauro Bove 240.000
L Thompson Bowles 60.000
Claudio Cavazza 10% Owner - [10%] 4.740.082 4.740.082
Paolo Cavazza 10% Owner - [10%] 1.500.000 349.891
David Crockford 35.000
Enrico Cavazza 10% Owner - [10%] 35.824.269 349.891
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Francesca Cavazza 10% Owner - [10%] 35.824.269 349.891
Preta Martina Cavazza 10% Owner - [10%] 35.824.269 349.891
Silvia Cavazza 10% Owner - [10%] 35.824.269 349.891
Consultadoria & Servicos SDC Unipessoal LDA Chaumiere 10% Owner - [10%] 4.555.985 4.555.985
Farmaceutica Lda Defiante 10% Owner - [10%] 12.937.111 129.371
R Don Elsey Director - [D] 104.456 1.045
SPA Essetifin 10% Owner - [10%] 34.989.080 349.891
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
J J Finkelstein President and CEO, Director - [D] [O] 1.712.991 17.130
G-treeBNT Co., Ltd. 10% Owner - [10%] 19.583.333 195.833
Allan L Goldstein Director - [D] 1.507.793 15.078
Richard J Hindin 15.000
C Neil Lyons 75.000
Joseph C Mcnay Director - [D] 6.524.122 65.241
Alessandro Noseda 240.000
Sinaf S.A. 10% Owner - [10%] 0 0

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i RGRX / RegeneRx Biopharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-06-30 FINKELSTEIN J J 75.000 0,2000 750 20,0000 15.000 12 31 8.250 55,00
2021-06-30 GOLDSTEIN ALLAN L 125.000 0,2000 1.250 20,0000 25.000
2021-06-30 CAVAZZA PAOLO 1.500.000 0,2000 15.000 20,0000 300.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RGRX / RegeneRx Biopharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i RGRX / RegeneRx Biopharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-03-13 Sinaf S.A. 11.584.795 0,2300 115.848 23,0000 2.664.503 335 0.1300 -2.649.442 -99,43

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RGRX / RegeneRx Biopharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2022-05-19 2022-05-17 4 GOLDSTEIN ALLAN L RGRX Stock Option (Right to Buy) A - Award D 0,19 480.000 480.000
2022-05-19 2022-05-17 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,19 240.000 240.000
2022-05-19 2022-05-17 4 Noseda Alessandro RGRX Stock Option (Right to Buy) A - Award D 0,19 240.000 240.000
2022-05-19 2022-05-17 4 Elsey R Don RGRX Stock Option (Right to Buy) A - Award D 0,19 290.000 290.000
2022-05-19 2022-05-17 4 FINKELSTEIN J J RGRX Stock Option (Right to Buy) A - Award D 0,19 600.000 600.000
2022-05-19 2022-05-17 4 MCNAY JOSEPH C RGRX Stock Option (Right to Buy) A - Award D 0,19 290.000 290.000
2022-03-02 2021-12-08 4 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -130.000 1.507.793
2021-08-04 2021-08-02 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,28 290.000 290.000
2021-08-04 2021-08-02 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,28 480.000 480.000
2021-08-04 2021-08-02 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,28 290.000 290.000
2021-08-04 2021-08-02 4 Noseda Alessandro RGRX Stock Option (right to buy) A - Award D 0,28 240.000 240.000
2021-08-04 2021-08-02 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,28 240.000 240.000
2021-08-04 2021-08-02 4 FINKELSTEIN J J RGRX Stock Option (right to buy) A - Award D 0,28 600.000 600.000
2021-07-19 3 APTAFIN S P A RGRX Common Stock D 1.500.000
2021-07-06 2021-06-30 4 GOLDSTEIN ALLAN L RGRX Series B Common Stock Warrant (right to buy) P - Purchase D 0,28 93.750 93.750
2021-07-06 2021-06-30 4 GOLDSTEIN ALLAN L RGRX Series A Common Stock Warrant (right to buy) P - Purchase D 0,24 93.750 93.750
2021-07-06 2021-06-30 4 GOLDSTEIN ALLAN L RGRX Common Stock P - Purchase D 0,2000 125.000 25 1.637.793
2021-07-06 2021-06-30 4 FINKELSTEIN J J RGRX Series B Common Stock Warrant (right to buy) P - Purchase D 0,28 56.250 56.250
2021-07-06 2021-06-30 4 FINKELSTEIN J J RGRX Series A Common Stock Warrant (right to buy) P - Purchase D 0,24 56.250 56.250
2021-07-06 2021-06-30 4 FINKELSTEIN J J RGRX Common Stock P - Purchase D 0,2000 75.000 15 1.712.991
2021-07-02 2021-06-30 4 CAVAZZA PAOLO RGRX Common Stock Warrant (right to buy) J - Other I 0,28 1.125.000 1.125.000
2021-07-02 2021-06-30 4 CAVAZZA PAOLO RGRX Common Stock Warrant (right to buy) J - Other I 0,24 1.125.000 1.125.000
2021-07-02 2021-06-30 4 CAVAZZA PAOLO RGRX Common Stock P - Purchase I 0,2000 1.500.000 300 1.500.000
2021-02-08 2020-02-13 5 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -200.000 1.512.793
2020-10-20 2020-10-15 4 GOLDSTEIN ALLAN L RGRX Common Stock Warrant (right to buy) P - Purchase D 0,45 10.440 10.440
2020-10-20 2020-10-15 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,36 5.000,0000
2020-10-20 2020-10-15 4 Bove Mauro RGRX Common Stock Warrant (right to buy) P - Purchase D 0,45 20.880 20.880
2020-10-20 2020-10-15 4 Bove Mauro RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,36 10.000,0000
2020-10-20 2020-10-15 4 FINKELSTEIN J J RGRX Common Stock Warrant (right to buy) P - Purchase D 0,45 20.880 20.880
2020-10-20 2020-10-15 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,36 10.000,0000
2020-10-16 2020-10-15 4 Essetifin SPA RGRX Common Stock Warrant (right to buy) J - Other D 0,45 835.189 835.189
2020-10-16 2020-10-15 4 Essetifin SPA RGRX Convertible Promissory Note (right to buy) P - Purchase D 400.000,0000
2020-06-12 2020-06-10 4 Noseda Alessandro RGRX Stock Option (right to buy) A - Award D 0,30 200.000 200.000
2020-06-12 2020-06-10 4 FINKELSTEIN J J RGRX Stock Option (right to buy) A - Award D 0,30 500.000 500.000
2020-06-12 2020-06-10 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,30 400.000 400.000
2020-06-12 2020-06-10 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,30 250.000 250.000
2020-06-12 2020-06-10 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,30 200.000 200.000
2020-06-12 2020-06-10 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,30 250.000 250.000
2019-08-28 2019-06-12 4 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -228.000 1.712.793
2019-05-17 2019-05-15 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,21 200.000 200.000
2019-05-17 2019-05-15 4 Noseda Alessandro RGRX Stock Option (right to buy) A - Award D 0,21 200.000 200.000
2019-05-17 2019-05-15 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,21 250.000 250.000
2019-05-17 2019-05-15 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,21 250.000 250.000
2019-05-17 2019-05-15 4 FINKELSTEIN J J RGRX Stock Option (right to buy) A - Award D 0,21 650.000 650.000
2019-05-17 2019-05-15 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,21 410.000 410.000
2019-05-16 2019-05-13 4 Essetifin SPA RGRX Common Stock Warrant (right to buy) J - Other D 0,18 3.125.000 3.125.000
2019-05-16 2019-05-13 4 Essetifin SPA RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 500.000,0000
2019-05-15 2019-05-13 4 Elsey R Don RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 15.625 15.625
2019-05-15 2019-05-13 4 Elsey R Don RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 2.500,0000
2019-05-15 2019-05-13 4 GOLDSTEIN ALLAN L RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 15.625 15.625
2019-05-15 2019-05-13 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 2.500,0000
2019-05-15 2019-05-13 4 MCNAY JOSEPH C RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 78.125 78.125
2019-05-15 2019-05-13 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 12.500,0000
2019-05-15 2019-05-13 4 FINKELSTEIN J J RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 78.125 78.125
2019-05-15 2019-05-13 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 12.500,0000
2019-05-15 2019-05-13 4 Bove Mauro RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 31.250 31.250
2019-05-15 2019-05-13 4 Bove Mauro RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 5.000,0000
2019-03-01 2019-02-26 4/A Essetifin SPA RGRX Common Stock Warrant (right to buy) J - Other D 0,18 3.125.000 3.125.000
2019-03-01 2019-02-26 4/A Essetifin SPA RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 500.000,0000
2019-03-01 2019-02-27 4 MCNAY JOSEPH C RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 78.125 78.125
2019-03-01 2019-02-27 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 12.500,0000
2019-03-01 2019-02-27 4 Elsey R Don RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 15.625 15.625
2019-03-01 2019-02-27 4 Elsey R Don RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 2.500,0000
2019-03-01 2019-02-27 4 Bove Mauro RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 31.250 31.250
2019-03-01 2019-02-27 4 Bove Mauro RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 5.000,0000
2019-03-01 2019-02-27 4 FINKELSTEIN J J RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 78.125 78.125
2019-03-01 2019-02-27 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 12.500,0000
2019-03-01 2019-02-27 4 GOLDSTEIN ALLAN L RGRX Common Stock Warrant (right to buy) P - Purchase D 0,18 15.625 15.625
2019-03-01 2019-02-27 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 2.500,0000
2019-02-27 2019-02-26 4 Essetifin SPA RGRX Common Stock Warrant (right to buy) J - Other D 0,18 2.884.615 2.884.615
2019-02-27 2019-02-26 4 Essetifin SPA RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,12 500.000,0000
2019-01-08 2019-01-06 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -522.280 0
2019-01-08 2019-01-06 4 MCNAY JOSEPH C RGRX Common Stock C - Conversion D 0,0600 522.280 31 6.524.122
2019-01-08 2019-01-06 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -208.912 0
2019-01-08 2019-01-06 4 GOLDSTEIN ALLAN L RGRX Common Stock C - Conversion D 0,0600 208.912 13 1.940.793
2018-09-28 2018-09-27 4 Essetifin SPA RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 150.000,0000 0
2018-09-28 2018-09-27 4 Essetifin SPA RGRX Common Stock C - Conversion D 0,0600 3.133.681 188 34.989.080
2018-09-13 2018-09-11 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -229.803 0
2018-09-13 2018-09-11 4 GOLDSTEIN ALLAN L RGRX Common Stock C - Conversion D 0,0600 229.803 14 1.731.881
2018-09-13 2018-09-11 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -2.089.120 0
2018-09-13 2018-09-11 4 MCNAY JOSEPH C RGRX Common Stock C - Conversion D 0,0600 2.089.120 125 6.001.842
2018-09-13 2018-09-11 4 Elsey R Don RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -104.456 0
2018-09-13 2018-09-11 4 Elsey R Don RGRX Common Stock C - Conversion D 0,0600 104.456 6 104.456
2018-07-19 2018-07-17 4 Elsey R Don RGRX Stock Option (Right to Buy) A - Award D 0,21 0,2100 200.000 42 325.000
2018-07-19 2018-07-17 4 FINKELSTEIN J J RGRX Stock Option (Right to Buy) A - Award D 0,21 0,2100 250.000 52 250.000
2018-07-19 2018-07-17 4 MCNAY JOSEPH C RGRX Stock Option (Right to Buy) A - Award D 0,21 0,2100 200.000 42 200.000
2018-07-19 2018-07-17 4 GOLDSTEIN ALLAN L RGRX Stock Option (Right to Buy) A - Award D 0,21 0,2100 250.000 52 250.000
2018-07-19 2018-07-17 4 Bove Mauro RGRX Stock Option (Right to Buy) A - Award D 0,21 0,2100 200.000 42 325.000
2018-07-09 2018-07-05 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -1.044.560 0
2018-07-09 2018-07-05 4 MCNAY JOSEPH C RGRX Common Stock C - Conversion D 0,0600 1.044.560 63 3.912.722
2018-07-09 2018-07-05 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -208.912 0
2018-07-09 2018-07-05 4 GOLDSTEIN ALLAN L RGRX Common Stock C - Conversion D 0,0600 208.912 13 1.502.078
2018-07-09 2018-07-05 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -104.456 0
2018-07-09 2018-07-05 4 FINKELSTEIN J J RGRX Common Stock C - Conversion D 0,0600 104.456 6 1.637.991
2018-04-02 2018-03-29 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -1.044.560 0
2018-04-02 2018-03-29 4 MCNAY JOSEPH C RGRX Common Stock C - Conversion D 0,0600 1.044.560 63 2.868.162
2018-04-02 2018-04-02 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,06 -522.280 0
2018-04-02 2018-03-29 4 GOLDSTEIN ALLAN L RGRX Common Stock C - Conversion D 0,0600 522.280 31 1.293.166
2018-04-02 2018-01-30 4 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -250.000 770.886
2018-03-14 2018-03-13 4 Sinaf S.A. RGRX Convertible Promissory Note (right to buy) S - Sale D 0,06 150.000,0000 0
2018-03-14 2018-03-13 4 Sinaf S.A. RGRX Common Stock S - Sale D 0,2300 -11.584.795 -2.665 0
2018-03-14 2014-02-03 4 Sinaf S.A. RGRX Common Stock J - Other D -64.575 11.584.795
2018-03-14 2018-03-13 4 Essetifin SPA RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,06 150.000,0000 2.500.000
2018-03-14 2018-03-13 4 Essetifin SPA RGRX Common Stock P - Purchase D 0,2300 6.348.878 1.460 31.855.399
2018-03-14 2018-03-13 4 Essetifin SPA RGRX Common Stock P - Purchase D 0,2300 11.584.795 2.665 25.506.521
2017-10-20 2017-10-19 4 GOLDSTEIN ALLAN L RGRX Common Stock Warrant (right to buy) X - Other D 0,15 -46.666 0
2017-10-20 2017-10-19 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,15 -292.477 0
2017-10-20 2017-10-19 4 GOLDSTEIN ALLAN L RGRX Common Stock X - Other D 0,1500 46.666 7 1.020.886
2017-10-20 2017-10-19 4 GOLDSTEIN ALLAN L RGRX Common Stock C - Conversion D 0,1500 292.477 44 974.220
2017-10-20 2017-10-19 4 MCNAY JOSEPH C RGRX Common Stock Warrant (right to buy) X - Other D 0,15 -66.667 0
2017-10-20 2017-10-19 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,15 -417.824 0
2017-10-20 2017-10-19 4 MCNAY JOSEPH C RGRX Common Stock X - Other D 0,1500 66.667 10 1.823.602
2017-10-20 2017-10-19 4 MCNAY JOSEPH C RGRX Common Stock C - Conversion D 0,1500 417.824 63 1.756.935
2017-10-20 2017-10-19 4 FINKELSTEIN J J RGRX Common Stock Warrant (right to buy) X - Other D 0,15 -20.000 0
2017-10-20 2017-10-19 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,15 -125.347 0
2017-10-20 2017-10-19 4 FINKELSTEIN J J RGRX Common Stock X - Other D 0,1500 20.000 3 1.533.535
2017-10-20 2017-10-19 4 FINKELSTEIN J J RGRX Common Stock C - Conversion D 0,1500 125.347 19 1.513.535
2017-10-17 2017-10-13 4 Sinaf S.A. RGRX Common Stock Warrant (right to buy) J - Other D 0,15 -266.667 0
2017-10-17 2017-10-13 4 Sinaf S.A. RGRX Convertible Promissory Note (right to buy) C - Conversion D 0,15 -1.671.296 0
2017-10-17 2017-10-13 4 Sinaf S.A. RGRX Common Stock J - Other D 266.667 11.649.370
2017-10-17 2017-10-13 4 Sinaf S.A. RGRX Common Stock C - Conversion D 1.671.296 11.382.703
2017-09-06 2017-09-01 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,28 125.000 125.000
2017-09-06 2017-09-01 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,28 125.000 125.000
2017-09-06 2017-09-01 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,28 150.000 150.000
2017-09-06 2017-09-01 4 FINKELSTEIN J J RGRX Stock Option (right to buy) A - Award D 0,28 150.000 150.000
2017-09-06 2017-09-01 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,28 125.000 125.000
2017-02-14 2016-12-30 5 FINKELSTEIN J J RGRX Common Stock G - Gift D -100.000 1.388.188
2017-02-14 2016-12-01 5 FINKELSTEIN J J RGRX Common Stock W - Other D 210.550 1.488.188
2017-02-06 2017-01-31 4 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -125.000 681.743
2016-07-15 2015-03-25 5 FINKELSTEIN J J RGRX Common Stock G - Gift D -100.000 1.277.638
2016-07-15 2016-04-19 4 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -65.000 806.743
2016-07-15 2016-04-11 4 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -60.000 871.743
2016-03-18 2016-03-16 4 FINKELSTEIN J J RGRX Stock Option (right to buy) A - Award D 0,64 200.000 200.000
2016-03-18 2016-03-16 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,64 100.000 100.000
2016-03-18 2016-03-16 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,64 100.000 100.000
2016-03-18 2016-03-16 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,64 100.000 100.000
2016-03-18 2016-03-16 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,64 200.000 200.000
2015-07-02 2015-06-30 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,36 100.000 100.000
2015-07-02 2015-06-30 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,36 100.000 100.000
2015-07-02 2015-06-30 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,36 100.000 100.000
2015-07-02 2015-06-30 4 FINKELSTEIN J J RGRX Stock Option (right to buy) A - Award D 0,36 500.000 500.000
2015-07-02 2015-06-30 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,36 250.000 250.000
2015-07-02 2015-03-16 4 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -125.000 931.743
2015-07-02 2014-09-29 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) A - Award D 0,15
2015-07-02 2014-09-29 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) D - Sale to Issuer D 0,15 0
2015-02-13 2015-02-11 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,19 100.000 100.000
2015-02-13 2015-02-11 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,19 100.000 100.000
2015-02-13 2014-09-29 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) A - Award D 0,15 15.000,0000 100.000
2015-02-13 2014-09-29 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) D - Sale to Issuer D 0,15 15.000,0000 0
2015-02-13 2015-02-11 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,19 100.000 100.000
2015-02-13 2014-09-29 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) A - Award D 0,15 50.000,0000 333.333
2015-02-13 2014-09-29 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) D - Sale to Issuer D 0,15 50.000,0000 0
2015-02-13 2015-02-11 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,19 100.000 100.000
2014-12-29 2014-06-02 4/A GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -250.103 1.056.743
2014-12-29 2014-06-02 4 GOLDSTEIN ALLAN L RGRX Common Stock G - Gift D -250.103 1.056.743
2014-09-03 2014-08-29 4 G-treeBNT Co., Ltd. RGRX Purchase Commitment (Obligation to buy) X - Other D 0,12 -8.333.333 0
2014-09-03 2014-08-29 4 G-treeBNT Co., Ltd. RGRX Common Stock X - Other D 0,1200 8.333.333 1.000 19.583.333
2014-04-01 2014-03-25 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,21 150.000 150.000
2014-04-01 2014-03-25 4 Bowles L Thompson RGRX Stock Option (right to buy) A - Award D 0,21 60.000 60.000
2014-04-01 2014-03-25 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,21 120.000 120.000
2014-04-01 2014-03-25 4 FINKELSTEIN J J RGRX Stock Option (right to buy) A - Award D 0,21 500.000 500.000
2014-04-01 2014-03-25 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,21 120.000 120.000
2014-04-01 2014-03-28 4 G-treeBNT Co., Ltd. RGRX Purchase Commitment (Obligation to buy) X - Other D 0,12 -11.250.000 0
2014-04-01 2014-03-28 4 G-treeBNT Co., Ltd. RGRX Common Stock X - Other D 0,1200 11.250.000 1.350 11.250.000
2014-04-01 2014-03-25 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,21 450.000 450.000
2014-01-09 2014-01-07 4 Bowles L Thompson RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 5.000,0000
2014-01-09 2014-01-07 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 25.000,0000
2014-01-09 2014-01-07 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 10.000,0000
2013-10-11 2013-07-05 4 Bowles L Thompson RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 5.000,0000
2013-10-11 2013-09-12 4 Elsey R Don RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 5.000,0000
2013-10-11 2013-09-12 4 Bowles L Thompson RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 5.000,0000
2013-10-11 2013-07-05 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 5.000,0000
2013-10-11 2013-07-05 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 50.000,0000
2013-10-11 2013-09-12 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 100.000,0000
2013-10-11 2013-07-05 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 10.000,0000
2013-10-11 2013-09-12 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 11.000,0000
2013-09-20 2013-09-12 4 CAVAZZA PAOLO Indirect RGRX Convertible Promissory Note (right to buy) P - Purchase I 0,06 150.000,0000
2013-09-20 2013-09-12 4 Sinaf S.A. RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,06 150.000,0000
2013-04-02 2013-03-29 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 50.000,0000
2013-04-02 2013-03-29 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) A - Award D 0,06 25.000,0000
2012-10-23 2012-10-19 4 Sinaf S.A. RGRX Common Stock Warrant (right to buy) J - Other D 0,15 1 1
2012-10-23 2012-10-19 4 Sinaf S.A. RGRX Convertible Promissory Note (right to buy) P - Purchase D 0,15 200.000,0000
2012-10-23 2012-10-19 4 CAVAZZA PAOLO Indirect RGRX Common Stock Warrant (right to buy) J - Other I 0,15 1 1
2012-10-23 2012-10-19 4 CAVAZZA PAOLO Indirect RGRX Convertible Promissory Note (right to buy) P - Purchase I 0,15 200.000,0000
2012-10-23 2012-10-19 4 FINKELSTEIN J J RGRX Common Stock Warrant (right to buy) A - Award D 0,15 20.000 20.000
2012-10-23 2012-10-19 4 FINKELSTEIN J J RGRX Convertible Promissory Note (right to buy) A - Award D 0,15 15.000,0000
2012-10-23 2012-10-19 4 MCNAY JOSEPH C RGRX Common Stock Warrant (right to buy) A - Award D 0,15 66.667 66.667
2012-10-23 2012-10-19 4 MCNAY JOSEPH C RGRX Convertible Promissory Note (right to buy) A - Award D 0,15 50.000,0000
2012-10-23 2012-10-19 4 GOLDSTEIN ALLAN L RGRX Common Stock Warrant (right to buy) A - Award D 0,15 46.666 46.666
2012-10-23 2012-10-19 4 GOLDSTEIN ALLAN L RGRX Convertible Promissory Note (right to buy) A - Award D 0,15 35.000,0000
2012-04-05 2012-04-03 4 Bove Mauro RGRX Stock Option (right to buy) A - Award D 0,16 50.000 50.000
2012-04-05 2012-04-03 4 Bowles L Thompson RGRX Stock Option (right to buy) A - Award D 0,16 50.000 50.000
2012-04-05 2012-04-03 4 CROCKFORD DAVID RGRX Stock Option (right to buy) A - Award D 0,16 35.000 35.000
2012-04-05 2012-04-03 4 Elsey R Don RGRX Stock Option (right to buy) A - Award D 0,16 50.000 50.000
2012-04-05 2012-04-03 4 FINKELSTEIN J J RGRX Stock Option (right to buy) A - Award D 0,16 35.000 35.000
2012-04-05 2012-04-03 4 MCNAY JOSEPH C RGRX Stock Option (right to buy) A - Award D 0,16 50.000 50.000
2012-04-05 2012-04-03 4 GOLDSTEIN ALLAN L RGRX Stock Option (right to buy) A - Award D 0,16 35.000 35.000
2012-01-26 2012-01-24 4 FINKELSTEIN J J RGRX Stock Options (right to buy) A - Award D 0,14 500.000 500.000
2012-01-26 2012-01-24 4 GOLDSTEIN ALLAN L RGRX Stock Options (right to buy) A - Award D 0,14 300.000 300.000
2011-01-07 2011-01-05 4 Essetifin SPA Indirect RGRX.OB Common Stock Warrants (right to buy) J - Other I 0,38 1 2
2011-01-07 2011-01-05 4 Essetifin SPA Indirect RGRX.OB Common Stock Warrants (right to buy) J - Other I 2,75 -1 0
2011-01-07 2011-01-05 4 Essetifin SPA Indirect RGRX.OB Common Stock Warrants (right to buy) J - Other I 0,38 1 1
2011-01-07 2011-01-05 4 Essetifin SPA Indirect RGRX.OB Common Stock Warrants (right to buy) J - Other I 4,06 -1 0
2011-01-07 2011-01-05 4 Essetifin SPA Indirect RGRX.OB Common Stock Warrants (right to buy) J - Other I 0,38 1 1
2011-01-07 2011-01-05 4 Essetifin SPA Indirect RGRX.OB Common Stock P - Purchase I 0,2700 925.926 250 12.937.111
2010-09-03 3 Elsey R Don RGN No securities are beneficially owned. D 0
2009-04-14 2009-04-10 4 Bowles L Thompson RGN Stock Options (right to buy) A - Award D 0,57 14.765 14.765
2008-12-19 2008-12-10 4/A CAVAZZA CLAUDIO Indirect RGN Common Stock P - Purchase I 1,4500 1.034.482 1.500 4.740.082
2008-12-19 3/A Chaumiere Consultadoria & Servicos SDC Unipessoal LDA RGN Common Stock D 4.555.985
2008-09-22 2008-09-15 4 Bove Mauro RGN Stock Options A - Award D 1,14 15.000 15.000
2008-09-22 2008-09-15 4 HINDIN RICHARD J RGN Stock Options A - Award D 1,14 15.000 15.000
2008-09-22 2008-09-15 4 MCNAY JOSEPH C RGN Stock Options A - Award D 1,14 15.000 15.000
2008-06-17 2008-06-15 4 Lyons C Neil RGN Stock Options A - Award D 1,50 75.000 75.000
2008-04-21 2008-04-15 4 CROCKFORD DAVID RGN Stock Options A - Award D 1,15 75.000 75.000
2008-04-17 2008-04-15 4 FINKELSTEIN J J RGN Stock Options A - Award D 1,15 125.000 125.000
2008-04-17 2008-04-15 4 GOLDSTEIN ALLAN L RGN Stock Options A - Award D 1,15 75.000 75.000
2008-03-03 2008-02-29 4 CAVAZZA PAOLO I RGN Common Stock Warrant (right to buy) J - Other I 1,60 1 1
2008-03-03 2008-02-29 4 CAVAZZA PAOLO I RGN Common Stock P - Purchase I 1,0000 2.500.000 2.500 4.555.985
2006-12-22 2006-12-21 4 Essetifin SPA I RGN Common Stock Warrant (right to buy) J - Other I 2,75 1 1
2006-12-22 2006-12-21 4 Essetifin SPA I RGN Common Stock P - Purchase I 1,8000 833.333 1.500 12.011.185
2006-07-18 2006-07-14 4 Essetifin SPA I RGN Common Stock Warrant (right to buy) X - Other I 1,50 -1 0
2006-07-18 2006-07-14 4 Essetifin SPA I RGN Common Stock X - Other I 1,5000 263.158 395 11.177.852
2006-03-08 2006-03-06 4 Essetifin SPA I RGN Warrant J - Other I 4,06 1 1
2006-03-08 2006-03-06 4 Essetifin SPA I RGN Common Stock P - Purchase I 2,8100 731.850 2.056 10.914.694
2005-06-24 2005-06-22 4 Essetifin SPA RGN Common Stock P - Purchase D 0 984.615
2005-06-24 2005-06-22 4 Essetifin SPA I RGN Common Stock P - Purchase I 3,2500 307.692 1.000 10.182.844
2004-09-07 2004-09-03 4 Essetifin SPA By Defiante Farmaceutica L.d.a. RGRX.OB Warrants X - Other I 1,08 -2 0
2004-09-07 2004-09-03 4 Essetifin SPA By Defiante Farmaceutica L.d.a. RGRX.OB Common Stock X - Other I 1,0850 1.382.488 1.500 9.875.151
2004-09-07 2004-09-02 4 Essetifin SPA By Defiante Farmaceutica L.d.a. RGRX.OB Warrants J - Other I 1,08 2 2
2004-01-26 2004-01-23 4 Essetifin SPA By Defiante Farmaceutica L.d.a. RGRX.OB Warrant J - Other I 1,25 1 1
2004-01-26 2004-01-23 4 Essetifin SPA By Defiante Farmaceutica L.d.a. RGRX.OB Warrant J - Other I 1,50 1 1
2004-01-26 2004-01-23 4 Essetifin SPA By Defiante Farmaceutica L.d.a. RGRX.OB Common Stock P - Purchase I 0,9500 1.052.631 1.000 8.492.663
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista